Scholarlink

<p>Guidelines are developed to ensure that patients are treated to the most uniform and quality-assured standards possible. The quality indicators provided in the S3 guidelines of the German Guideline Program Oncology serve to check adherence to treatment recommendations. Within this program, guidelines and quality indicators have now been developed for over 30&#xa0;types of cancer; however, they currently do not cover every disease or every treatment recommendation. Owing to the nationwide nature of data collection, cancer registries can evaluate adherence to quality indicators in all institutions providing cancer care. Moreover, in addition to assessing quality indicators, these unique data collections provide the opportunity to analyse further health care indicators, which may be developed by the registries themselves or in collaboration with external experts. The current study describes the development and application of two quality indicators for the time between diagnosis and surgery and the time between surgery and the end of the first curative treatment for head and neck cancer. The results reveal optimal care of patients with head and neck tumors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neue Versorgungsindikatoren geben Einblick in die Behandlungszeiträume von Kopf-Hals-Tumoren

  • 期刊论文

  • 发表日期：

    2025年12月15日

查看全文
  • Philipp Becker,
  • Andreas Pabst,
  • Sinaida Branscheidt,
  • Fabian Reinwald,
  • Philipp Morakis,
  • Jacqueline Müller-Nordhorn,
  • Constanze Schneider,
  • Sabine Luttmann,
  • Alice Nennecke,
  • Soo-Zin Kim-Wanner,
  • Annika Heßmer,
  • Kerstin Weitmann,
  • Tonia Brand,
  • Hiltraud Kajüter,
  • Bernd Holleczek,
  • Antje Niedostatek,
  • Alexander Kluttig,
  • Alexander Katalinic,
  • Klaus Kraywinkel,
  • Christina Justenhoven

摘要

Guidelines are developed to ensure that patients are treated to the most uniform and quality-assured standards possible. The quality indicators provided in the S3 guidelines of the German Guideline Program Oncology serve to check adherence to treatment recommendations. Within this program, guidelines and quality indicators have now been developed for over 30 types of cancer; however, they currently do not cover every disease or every treatment recommendation. Owing to the nationwide nature of data collection, cancer registries can evaluate adherence to quality indicators in all institutions providing cancer care. Moreover, in addition to assessing quality indicators, these unique data collections provide the opportunity to analyse further health care indicators, which may be developed by the registries themselves or in collaboration with external experts. The current study describes the development and application of two quality indicators for the time between diagnosis and surgery and the time between surgery and the end of the first curative treatment for head and neck cancer. The results reveal optimal care of patients with head and neck tumors.